Efficacy and Safety of Inotuzumab Ozogamicin in Treating Adult Patients With Ph Negative ALL With Minimal Residual Disease Positive After Induction Chemotherapy
Institute of Hematology & Blood Diseases Hospital, China
Institute of Hematology & Blood Diseases Hospital, China
University of Washington
Thomas Jefferson University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Memorial Sloan Kettering Cancer Center
Northside Hospital, Inc.
Masonic Cancer Center, University of Minnesota
H. Lee Moffitt Cancer Center and Research Institute
University of Chicago
St. Jude Children's Research Hospital
The First Affiliated Hospital of Soochow University
Memorial Sloan Kettering Cancer Center
The First Affiliated Hospital of Soochow University
Charite University, Berlin, Germany
City of Hope Medical Center
Fred Hutchinson Cancer Center
City of Hope Medical Center
M.D. Anderson Cancer Center
Gruppo Italiano Malattie EMatologiche dell'Adulto
M.D. Anderson Cancer Center
Baptist Health South Florida
Fred Hutchinson Cancer Center
Case Comprehensive Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Institute of Hematology & Blood Diseases Hospital, China
Dana-Farber Cancer Institute
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Ruijin Hospital
University of Alberta
Institute of Hematology & Blood Diseases Hospital, China
H. Lee Moffitt Cancer Center and Research Institute
Children's Hospital of Philadelphia
M.D. Anderson Cancer Center
City of Hope Medical Center
Dana-Farber Cancer Institute